US Broker Ratings

Embecta Corp. (EMBC) Stock Analysis: Uncovering a 76.79% Potential Upside in the Healthcare Sector

Embecta Corp. (NASDAQ: EMBC), a seasoned player in the healthcare sector, specializes in medical instruments and supplies with a focus on diabetes management solutions. With a market capitalization of $586.76..

Rocket Pharmaceuticals, Inc. (RCKT): An Investor Outlook on Potential 209% Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) represents a compelling opportunity within the biotechnology sector, especially for those investors who are willing to embrace the risk for potentially high rewards. With a..

Keros Therapeutics, Inc. (KROS) Stock Analysis: A Biotech Player with Over 100% Potential Upside

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, is capturing investor attention with its significant growth potential and a promising pipeline of innovative therapeutics. Based in Lexington, Massachusetts, Keros..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: Exploring a 131.74% Upside Potential in the Biotech Sector

Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a promising player in the biotechnology sector, has caught the attention of investors with its impressive potential upside and strategic focus on rare diseases. Headquartered..

Zymeworks Inc. (ZYME) Stock Analysis: Unraveling the 64.55% Upside Potential for Biotech Investors

Zymeworks Inc. (NASDAQ: ZYME) stands at a pivotal juncture in the biotechnology sector, presenting a substantial potential upside of 64.55% according to recent analyst ratings. With its innovative approach to..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Biotech Terrain with Strategic Insights

Ginkgo Bioworks Holdings, Inc. (DNA), a pioneer in the biotechnology industry, is making waves with its innovative approach to cell programming. Headquartered in Boston, Massachusetts, Ginkgo Bioworks has carved a..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Uncovering a Potential 311% Upside in Biotech Innovation

Relay Therapeutics, Inc. (NASDAQ: RLAY) stands at the forefront of biotechnology innovation, with its clinical-stage precision medicines targeting oncology and genetic diseases. Based in Cambridge, Massachusetts, the company is revolutionizing..

LifeMD, Inc. (LFMD) Stock Analysis: A 48.8% Revenue Growth Story in Telehealth

LifeMD, Inc. (NASDAQ: LFMD) has positioned itself as a compelling player in the burgeoning telehealth sector, attracting attention with a robust revenue growth rate of 48.8%. The company’s market capitalization..

Claritev Corporation (CTEV) Stock Analysis: Navigating Turbulence with Strategic Data Analytics

Claritev Corporation (NASDAQ: CTEV), a key player in the healthcare sector’s dynamic landscape, primarily operates within the health information services industry. As a burgeoning entity headquartered in New York, the..

Xeris Biopharma Holdings (XERS): Investor Outlook Reveals 42% Upside Potential

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is catching the attention of investors with its promising growth trajectory and the potential for significant upside in its stock price. As a commercial-stage..

CureVac N.V. (CVAC) Investor Outlook: Analyzing Growth Potential Amidst a 5.91% Upside

CureVac N.V. (NASDAQ: CVAC), a pioneering entity in the biotechnology sector, is positioning itself as a formidable player in the mRNA technology space. Headquartered in Tübingen, Germany, CureVac’s innovative approach..

Definitive Healthcare Corp. (DH) Stock Analysis: A Closer Look at a Potential 12.95% Upside

Definitive Healthcare Corp. (NASDAQ: DH), a prominent player in the healthcare information services sector, operates a robust software as a service (SaaS) platform. This platform provides comprehensive healthcare commercial intelligence..

InMode Ltd. (INMD) Stock Analysis: Healthcare Innovator with 21% Upside Potential

For investors on the lookout for promising opportunities in the healthcare sector, InMode Ltd. (NASDAQ: INMD) presents a compelling case. With a market capitalization of $888.09 million, this Israeli medical..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Unveiling a 67.72% Potential Upside in the Medical Device Sector

OrthoPediatrics Corp. (NASDAQ: KIDS) is carving out a significant niche within the healthcare sector, specifically in the medical devices industry focused on pediatric orthopedic solutions. With a market capitalization of..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating the 22.74% Potential Upside

AMN Healthcare Services Inc (NYSE: AMN) stands as a key player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Dallas, Texas, AMN has carved a..

Valneva SE (VALN) Investor Outlook: A 117% Potential Upside in Biotechnology

Valneva SE (VALN), a French biotechnology company specializing in prophylactic vaccines, is capturing the attention of investors with its promising financial outlook and substantial potential upside. With a market capitalization..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Promising 89.3% Upside in the Biotech Sector

Stoke Therapeutics, Inc. (NASDAQ: STOK), a pioneering entity in the biotechnology industry, is capturing investor attention with a compelling potential upside of 89.3%. This early-stage biopharmaceutical company operates primarily in..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Unraveling a 363% Potential Upside in the Biotech Arena

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is making waves in the biotechnology sector, driven by its pioneering work in cell therapies aimed at treating metastatic melanoma and other solid tumor cancers...

Eton Pharmaceuticals (ETON) Stock Analysis: A 104% Upside Potential with Robust Revenue Growth

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) has emerged as a notable player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic medications. Founded in 2017..

Butterfly Network, Inc. (BFLY) Stock Analysis: Navigating a 70% Potential Upside in the Medical Device Sector

Butterfly Network, Inc. (NYSE: BFLY) stands as a transformative player within the healthcare sector, specifically in the medical devices industry. Renowned for its innovative ultrasound imaging solutions, the company is..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds